Dermatology News
- ICIs in Melanoma: Predicting Immune-related Adverse Events
- Keeping Injectable Products in Cosmetic Dermatology Safe
- FDA approves topical treatment for junctional, dystrophic EB
- Study Links Specific Drugs to Delusions of Parasitosis Risk
- Paradoxical Eczema Risk Low With Biologic Psoriasis Tx
- Evaluating Aesthetic Concerns Among Hispanic, Latinx Women
- Alert Roflumilast Foam Gets Nod for Seborrheic Dermatitis
- How Does Lebrikizumab Perform Across Different Subgroups?
- GVHD Raises Vitiligo Risk in Transplant Recipients
- Growing Mpox Outbreak Prompts CDC Health Advisory
- Checkpoint Therapeutics Slides After US FDA Declines Cancer Therapy Approval
- Infections Down in Acute Care Hospitals
- Pilot Study Educates Barbers About Pseudofolliculitis Barbae
- Alert FDA Approves Tralokinumab for Treating Eczema in Adolescents
- Top 10 Fictional Docs on Streaming TV
- Disease Control Elusive for Many Patients on AD Therapies
- Alert Antiparasitic Wins FDA Approval for High-Risk Neuroblastoma
- Acne in Primary Care: The Best of Times?
- Acne Stigma Persists Across Social and Professional Settings
- US Consumer Group Seeks Stronger Warnings on Botox, Similar Treatments
- Bimekizumab Promising for Palmoplantar Pustular Psoriasis
- MSWS 2023 What's New in Acne Treatment?
- Analysis Supports Link Between Psoriasis and OSA
- MSWS 2023 New Tools Available to Help Diagnose Skin Cancer
- MSWS 2023 Misdiagnoses Among Challenges in Managing Cutaneous Lymphoma
- EADV 2023 Novel Subcutaneous Biologics Show Promise in AD
- Meta-Analysis: Suicide Risk Not Increased With Isotretinoin
- Dietary Supplements May Play a Role in Managing Vitiligo
- Pilonidal Disease: Study Finds Laser Hair Removal Beneficial
- Tapinarof Effective for AD in Patients as Young as 2 years
- Nail Psoriasis in Black Patients Often Overlooked
- Alert FDA Warns of Potentially Lethal Reaction to Seizure Meds
- EADV 2023 At 52 Weeks, Hair Growth Still Climbing on Deuruxolitinib
- Methotrexate Carries Higher Risk for Older CKD Patients
- Parent Concerns a Factor When Treating Patients With AD
- Questionnaire Measures Patient Satisfaction With Acne Tx
- Risks Quantified in Medically Optimized Pregnancy With Lupus
- Choosing the Right Approach to Cancer and Menopause Symptoms
- Circadian Calorie-Burning Cycles Altered in Obesity
- ACR 2023 IV Secukinumab Trials Hit Primary Endpoints in PsA, AxSpA